Latest news

• IBM teams up with Teva for global eHealth collaboration

  Willalso partner with ICON on cancer trials project. IBM has signed deals with Teva and ICON that will see the firms use services based on its Watson supercomputer. ... This will be applied to breast, lung, colon and rectal cancer trials and aims to

• Valeant and Shire said to be evaluating potential Salix bids

  Valeant currently in final stages of Provenge acquisition. Valeant Pharmaceuticals is in the final stages of acquiring Dendreon's cancer vaccine Provenge but is already lining up its next acquisition prospect, ... Nevertheless, in the latter half of last

• Close but no cigar

  Despite failure to show clinical benefit, gene therapy continues to offer hope for cancer treatment. ... TNFerade has also shown potential in the treatment of rectal cancer, head and neck cancer, metastatic melanoma and oesophageal cancer.

• Roche and Pfizer report growth

  Sales of the osteoporosis drug Bonviva, and the cancer therapy Avastin, which were up 41 per cent and 37 per cent respectively, contributed to the successful sales story to date. ... cancer). US revenue has decreased by 13 per cent. However, the

• Contraceptive pill may protect against cancer

  In the main dataset women on the pill had statistically significant lower rates of large bowel/rectal, uterine body and ovarian cancer. ... The GP dataset also showed a reduced risk of uterine and ovarian cancer.